hypothyroidism: Abnormally low levels of thyroid hormone.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
209 |
4. Check minimum number of eventsNone |
209 |
5. Include endpointsNone |
209 |
6. Filter based on genotype QC (FinnGen only) |
203 |
Control definitions (FinnGen only)
- Control exclude
- E4_THYROID
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E03
- Name in latin
- Hypothyreosis postinfectiosa
Similar endpoints
↥List of similar endpoints to
Postinfectious hypothyroidism
based on the number of shared cases.
Similar with more cases:
- Hypothyroidism (congenital or acquired)
- Hypothyreosis and Thyroxine purchase for inclusion criteria
- Disorders of the thyroid gland
- Used for control exclusion in common control thyroid runs
- Endocrine, nutritional and metabolic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2062 | 1681 | 349 |
| Only index persons | 1434 | 1198 | 236 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.01 |
| Only index persons | 0.04 | 0.04 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 55.61 | 56.08 | 52.28 |
| Only index persons | 48.62 | 49.33 | 45.03 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 203 | 168 | 35 |
| Unadjusted period prevalence (%) | 0.05 | 0.06 | 0.02 |
| Median age at first event (years) | 42.19 | 40.93 | 48.20 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 209
- Matched controls
- 2090
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H03AA01
ATC
levothyroxine sodium; systemic
1443.5
238.8
201
35
104
Kela drug reimbursment
Thyroid insufficiency
1948.2
187.0
154
*
2448A
ICD-9 Finland
Acquired hypothyroidism, Other specified acquired hypothyroidism[HYPOTHYREOSIS POST THYREOIDITIDEM]
+∞
172.8
141
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
400.3
147.4
133
9
E03.3
ICD-10 Finland
Postinfectious hypothyroidism
+∞
80.5
72
*
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
564.6
47.3
45
*
A10AA02, ,
ATC
18.8
47.3
40
26
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
16.9
43.7
39
28
E03
ICD-10 Finland
Other hypothyroidism
261.1
42.6
42
*
A10AA01, ,
ATC
18.1
40.9
35
23
E03.89
ICD-10 Finland
Other specified hypothyroidism
245.8
40.4
40
*
A10AB01
ATC
insulin (human); parenteral
15.3
40.3
38
30
A10AB04
ATC
insulin lispro; parenteral
16.6
39.2
35
25
T89
ICPC
Diabetes insulin dependent
13.4
35.4
36
32
A10AC01
ATC
insulin (human); parenteral
7.6
30.5
50
83
A10AB05
ATC
insulin aspart; parenteral
7.7
28.8
46
74
A10AE04
ATC
insulin glargine; parenteral
6.5
26.4
50
96
T86
ICPC
Hypothyroidism/myxoedema
282.4
25.2
25
*
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
25.1
24.4
34
16
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
21.2
21.2
31
17
A10AE05
ATC
insulin detemir; parenteral
7.7
20.6
31
46
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
+∞
18.0
17
*
E10
ICD-10 Finland
Type 1 diabetes mellitus
55.0
17.3
20
*
H04AA01
ATC
glucagon; nasal, parenteral
25.6
16.8
23
10
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
17.3
16.7
26
17
103
Kela drug reimbursment
Diabetes, insulin-treated
3.5
16.4
84
340
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.4
15.5
77
304
XCK10
NOMESCO Finland
Photography of fundus of eye
4.6
14.3
38
96
E03.8
ICD-10 Finland
Other specified hypothyroidism
+∞
13.7
13
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
149.3
13.6
14
*
A10AD01
ATC
insulin (human); parenteral
14.4
12.7
21
16
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
10.2
11.8
23
25
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
32.1
11.8
15
5
A10AE06
ATC
insulin degludec; parenteral
10.1
11.3
22
24
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.6
11.2
42
136
H3603, E103,
ICD-10 Finland
63.3
10.7
12
*
K29.4
ICD-10 Finland
Chronic atrophic gastritis
13.1
10.0
17
14
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
57.7
9.7
11
*
SPAT1262
SPAT
Handing over of treatment supplies
3.0
9.6
49
191
B03BA03
ATC
hydroxocobalamin; parenteral
4.5
9.0
23
56
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
8.6
108
650
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
28.9
8.6
11
*
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
34.8
8.2
10
*
J01FF01
ATC
clindamycin; systemic
2.5
8.1
68
340
A12AA04
ATC
calcium carbonate; oral
23.1
8.1
11
5
4019X
ICD-9 Finland
Essential hypertension, Unspecified
7.9
7.8
17
23
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
7.8
52
232
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
10.6
7.7
14
14
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
7.5
76
411
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
82.9
7.5
8
*
24409
ICD-8 Finland
Myxoedema, (hypothyreosis) NUD
82.9
7.5
8
*
107
Kela drug reimbursment
Pernicious anaemia
11.5
7.4
13
12
E06.3
ICD-10 Finland
Autoimmune thyroiditis
+∞
7.3
7
*
A11CC03
ATC
alfacalcidol; systemic
10.6
7.1
13
13
CKC12
NOMESCO Finland
Photocoagulation of retina
4.7
7.1
17
39
A10AA03, ,
ATC
14.4
7.0
11
8
A12BA01
ATC
potassium chloride; oral
4.4
7.0
18
44
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.5
6.9
17
40
N06AA09
ATC
amitriptyline; systemic
3.1
6.8
31
112
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
41.4
6.8
8
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
12.8
6.7
11
9
SPAT1263
SPAT
Sampling
2.1
6.5
97
608
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
72.0
6.5
7
*
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
9.7
6.4
12
13
E03.1
ICD-10 Finland
Congenital hypothyroidism without goitre
+∞
6.3
6
*
H03BB01
ATC
carbimazole; oral
27.6
6.3
8
*
H3600, E103,
ICD-10 Finland
27.6
6.3
8
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.2
6.2
63
337
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
6.2
27
95
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
183
1280
4.45
13.08
10.1
2.6
16.50
14.50
pmol/l
13.93
173
1167
28
69
4.53
10.81
4.0
4.1
1.50
1.74
mmol/l
0.13
21
55
81
461
2.24
7.02
6.9
3.7
17.65
5.67
mg/mmol
1.16
55
277
120
809
2.13
6.66
11.1
5.5
1.21
1.22
mmol/l
1.06
99
697
101
641
2.11
6.53
2.0
1.9
108.15
95.83
pmol/l
1.10
49
313
136
974
2.13
6.29
6.8
3.8
7.87
6.60
mmol/l
4.45
126
914
108
722
2.03
5.89
9.6
4.7
1.21
1.22
mmol/l
0.76
97
669
55
291
2.21
5.53
1.7
1.7
1362.24
1278.33
nmol/l
0.13
50
221
105
711
1.96
5.37
2.9
2.2
75.93
77.05
nmol/l
0.15
97
647
132
972
1.97
5.21
9.1
9.1
4.18
4.15
e9/l
0.05
120
855
61
359
1.99
4.55
2.0
1.8
1942.88
466.43
pmol/l
0.49
51
306
162
1316
2.03
4.40
9.5
6.8
82.76
77.03
u/l
0.61
156
1235
184
1573
2.42
4.31
12.0
3.5
1.77
1.87
mu/l
0.12
173
1440
77
499
1.86
4.27
2.5
2.0
100.40
199.53
u/l
1.81
72
466
87
587
1.83
4.24
4.4
2.8
—
—
—
0
0
104
750
1.77
3.99
9.2
13.7
1.25
1.21
inr
0.16
29
226
116
867
1.76
3.90
4.4
3.9
0.00
0.02
estimate
0.50
23
156
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
28
4.48
3.88
2.7
2.9
0.21
0.29
u/ml
—
6
17
95
672
1.76
3.86
4.5
4.0
—
—
—
0
0
61
379
1.86
3.81
1.7
1.5
17.89
22.09
nmol/l
2.04
54
330
43
242
1.98
3.59
2.3
1.8
—
—
—
0
0
9
17
5.48
3.55
1.6
1.1
—
—
—
0
0
113
854
1.70
3.52
6.0
5.3
0.04
0.01
estimate
0.39
24
164
91
649
1.71
3.51
3.9
3.7
49.53
30.94
ng/l
0.45
60
436
112
852
1.68
3.35
4.4
3.9
0.00
0.00
estimate
-0.00
28
177
34
184
2.01
3.15
5.6
4.5
35.81
32.28
%
0.97
26
119
56
365
1.73
2.91
1.4
1.2
0.92
2.08
u/ml
—
6
104
12
39
3.20
2.82
6.4
2.2
—
—
—
0
0
22
106
2.20
2.74
2.1
1.5
—
—
—
0
0
94
719
1.56
2.53
7.0
3.5
34.88
35.80
g/l
0.86
88
673
151
1290
1.61
2.46
6.9
4.2
13.38
11.68
mm/h
0.89
136
1192
51
341
1.66
2.38
1.5
1.3
24.81
31.63
iu/ml
0.21
17
117
11
39
2.92
2.38
1.0
1.1
—
2.99
—
0
9
56
388
1.61
2.27
1.7
1.6
1.29
1.06
mg/l
0.20
42
311
18
87
2.17
2.24
2.3
1.7
—
—
—
0
0
14
61
2.39
2.20
2.8
1.9
—
—
—
0
0
64
462
1.56
2.17
3.8
2.7
0.61
0.38
e6/l
0.31
51
341
7
19
3.77
2.17
1.1
1.1
—
—
—
0
0
6
14
4.38
2.16
2.2
2.1
—
—
—
0
0
6
163
0.35
2.12
1.3
1.7
—
—
—
0
0
18
90
2.09
2.07
1.3
1.2
126.03
91.62
iu/ml
—
10
31
6
15
4.08
2.05
1.7
1.3
—
—
—
0
0
48
329
1.60
2.02
1.5
1.3
4.35
10.20
u/ml
0.84
21
127
9
33
2.80
1.95
1.4
1.7
—
—
—
0
0
20
107
1.96
1.94
8.7
3.0
149.71
77.52
ng/l
0.86
15
98
44
299
1.60
1.92
1.5
1.5
—
—
—
0
0
187
1722
1.82
1.91
22.3
13.0
21.44
22.43
mg/l
0.16
163
1346
188
1736
1.83
1.87
25.7
14.5
139.01
139.70
mmol/l
2.85
182
1691
63
468
1.50
1.84
4.8
4.1
0.00
0.01
estimate
0.50
23
167
39
260
1.61
1.83
4.1
2.6
2.07
1.17
e6/l
0.33
24
142
94
756
1.44
1.83
4.3
2.6
68.48
87.74
ug/l
1.79
89
696
23
132
1.83
1.82
5.0
3.6
1.22
1.23
mmol/l
0.52
18
119
9
36
2.57
1.76
1.2
1.5
—
—
—
0
0
17
91
1.94
1.66
7.2
4.4
25.87
25.13
mmol/l
0.35
17
91
27
168
1.70
1.65
2.1
1.8
—
—
—
0
0
5
14
3.63
1.62
1.0
1.5
—
—
—
0
0
10
43
2.39
1.61
1.0
1.3
—
—
—
0
0
187
1739
1.72
1.61
26.0
14.5
3.98
3.95
mmol/l
0.81
181
1687
62
471
1.45
1.60
2.9
2.9
1851.43
1161.35
ng/l
0.39
52
401
8
33
2.48
1.55
1.4
1.4
—
—
—
0
0
6
21
2.91
1.51
1.0
1.5
—
—
—
0
0
6
21
2.91
1.51
1.3
1.1
—
—
—
0
0
26
165
1.66
1.49
2.0
1.7
—
—
—
0
0
51
379
1.46
1.47
4.5
4.1
1.01
1.01
kg/l
0.30
12
56
12
59
2.10
1.46
2.8
1.8
—
—
—
0
0
6
22
2.78
1.44
1.2
1.2
—
—
—
0
0
6
22
2.78
1.44
1.2
1.2
—
—
—
0
0
6
22
2.78
1.44
1.2
1.2
—
—
—
0
0
6
22
2.78
1.44
1.2
1.2
—
—
—
0
0
6
22
2.78
1.44
1.5
1.4
—
—
—
0
0
6
22
2.78
1.44
1.5
1.4
—
—
—
0
0
6
22
2.78
1.44
1.2
1.2
—
—
—
0
0
95
792
1.37
1.41
2.8
2.4
—
—
—
0
0
73
585
1.38
1.38
2.6
3.1
2.33
2.36
mmol/l
0.86
65
522
6
23
2.65
1.37
1.7
1.4
—
—
—
0
0
53
402
1.43
1.37
2.5
2.2
337.02
7177.96
umol/l
2.28
42
358
9
42
2.19
1.35
1.0
1.2
—
—
—
0
0
8
34
2.41
1.30
1.6
1.4
—
—
—
0
0
53
406
1.41
1.30
2.5
2.1
—
—
—
0
0
34
241
1.49
1.24
3.9
2.8
2.48
3.92
e6/l
0.46
18
124
11
57
1.98
1.19
1.5
1.1
—
—
—
0
0
5
20
2.54
1.16
1.2
1.5
—
—
—
0
0
5
20
2.54
1.16
1.6
1.4
—
—
—
0
0
172
1600
1.42
1.14
20.3
12.0
74.47
81.07
ml/min/173m2
2.89
144
1307
8
40
2.04
1.13
1.3
1.2
—
—
—
0
0
7
31
2.30
1.11
1.1
1.4
—
—
—
0
0
122
1085
1.30
1.06
3.6
3.2
—
—
—
0
0
9
46
2.00
1.05
1.0
3.0
—
4.14
—
0
5
39
294
1.40
1.05
6.1
3.5
548.73
222.66
ng/l
0.34
30
211
5
22
2.30
1.04
1.2
1.2
—
—
—
0
0
58
471
1.32
0.98
1.8
1.6
1.46
1.36
mmol/l
0.35
50
402
7
37
1.92
0.95
1.0
1.3
—
—
—
0
0
6
28
2.18
0.92
1.2
1.5
—
—
—
0
0
169
1586
1.34
0.90
9.4
5.4
46.29
39.30
mmol/mol
7.52
157
1489
6
30
2.03
0.87
1.5
1.3
—
—
—
0
0
6
31
1.96
0.85
1.7
2.7
53.50
64.77
%
—
6
31
6
32
1.90
0.82
4.0
1.6
136.50
132.29
g/l
—
6
21
23
165
1.44
0.82
2.0
3.2
—
—
—
0
0
8
47
1.73
0.81
3.5
4.3
11.43
33.88
mg/l
—
8
30
6
34
1.79
0.77
1.5
1.3
—
—
—
0
0
9
54
1.70
0.75
1.2
1.1
—
—
—
0
0
5
24
2.11
0.75
1.4
1.1
—
—
—
0
0
14
93
1.54
0.71
4.5
2.5
1.42
1.15
%
0.69
14
93
7
42
1.69
0.69
1.0
1.4
—
2.57
—
0
11
5
28
1.80
0.66
1.8
1.3
—
—
—
0
0
5
28
1.80
0.66
1.8
1.3
—
—
—
0
0
21
157
1.38
0.62
1.3
1.9
—
—
—
0
0
8
54
1.50
0.58
1.4
1.8
—
—
—
0
0
14
99
1.44
0.55
12.4
6.6
93.37
94.14
%
0.19
14
99
13
91
1.46
0.54
1.6
1.5
—
—
—
0
0
22
170
1.33
0.54
1.3
2.0
—
—
—
0
0
6
39
1.55
0.53
1.3
1.2
—
—
—
0
0
6
99
0.59
0.53
1.0
1.6
—
—
—
0
0
187
1820
1.26
0.42
15.6
9.7
25.77
24.71
u/l
0.37
181
1764
13
97
1.36
0.40
14.4
7.7
23.03
24.77
mmol/l
0.68
13
91
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
37
326
1.16
0.31
2.4
2.4
2.44
2.45
mmol/l
0.35
31
281
7
54
1.31
0.30
1.3
1.3
—
—
—
0
0
13
159
0.81
0.26
5.8
4.8
21.44
22.08
%
—
7
79
5
39
1.29
0.23
1.0
1.2
—
47.08
—
0
6
0
11
0.00
0.21
0.0
1.9
—
46.88
—
0
11
0
10
0.00
0.21
0.0
1.1
—
161.76
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
6
53
1.14
0.19
1.3
1.7
—
—
—
0
0
7
87
0.80
0.15
1.0
1.0
—
—
—
0
0
183
1808
1.10
0.13
26.4
15.2
86.44
71.93
umol/l
1.98
183
1808
191
1893
1.10
0.10
33.2
19.4
263.29
256.18
e9/l
0.77
185
1855
5
45
1.11
0.10
1.8
1.8
—
—
—
0
0
38
361
1.06
0.09
1.6
1.4
—
—
—
0
0
167
1689
0.94
0.09
6.2
4.2
1.56
1.56
mmol/l
0.05
152
1567
13
144
0.90
0.08
2.9
2.8
41.25
70.58
ml/min/173m2
—
8
60
191
1895
1.09
0.08
33.1
19.3
4.40
4.43
e12/l
0.47
185
1849
191
1895
1.09
0.08
33.3
19.3
38.75
39.61
%
0.96
178
1781
117
1149
1.04
0.08
4.3
2.7
71.54
41.64
u/l
1.51
109
1085
6
75
0.79
0.07
1.5
1.6
—
—
—
0
0
161
1625
0.96
0.06
5.7
3.8
1.30
1.23
mmol/l
0.73
148
1501
168
1694
0.96
0.05
6.3
4.2
4.61
4.77
mmol/l
1.51
157
1581
151
1495
1.04
0.05
25.3
15.5
15.79
14.92
%
0.81
145
1476
19
199
0.95
0.03
6.4
7.2
—
—
—
0
0
167
1661
1.03
0.02
5.7
4.4
6.75
5.84
mmol/l
4.24
152
1528
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
2.1
—
115.11
—
0
9
6
61
0.98
-0.00
1.2
1.1
—
—
—
0
0
9
99
0.91
-0.00
1.4
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
16.50
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
173
1730
1.00
-0.00
6.7
4.7
2.60
2.80
mmol/l
2.42
159
1603
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
61
0.98
-0.00
1.2
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
12.92
—
0
6
0
8
0.00
-0.00
0.0
1.3
—
30.74
—
0
8
Mortality – FinRegistry
↥Association
Association between endpoint E4_HYTHYPOSTINF and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_HYTHYPOSTINF | 1.889 [1.3, 2.75] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.278 |
During the follow-up period (1.1.1998 — 31.12.2019), 115 out of 430 females with E4_HYTHYPOSTINF died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have E4_HYTHYPOSTINF.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.184% | No data |
| 5 | 1.234% | No data |
| 10 | 2.848% | No data |
| 15 | 5.051% | No data |
| 20 | 9.149% | No data |
Relationships between endpoints
↥Index endpoint: E4_HYTHYPOSTINF – Postinfectious hypothyroidism
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data